9
67.9, 67.6, 66.4, 61.5, 20.8, 20.7, 20.7, 20.6, 20.6, 20.1; FT-IR
(KBr, cm–1): 1755, 1554, 1522, 1370, 1346, 1234, 1038.
MALDI-TOF-MS, [M+Na]+ = 780.19 (calc. 780.21).
Before the titration experiments, we prepared the aqueous
ACCEPTED MANUSCRIPT
metalloglycocluster solutions and the aqueous salt solutions as
the stock solutions. In the case of the former, we mixed the
glycobpys and FeCl2 in water to prepare the aqueous
metalloglycocluster solutions ([bpyMal], [bpyLac], or [bpyIma]
= 24.4 mM, [FeCl2] = 73.3 mM). We then mixed the
metalloglycocluster solutions (3 µl), aqueous salt solutions (0–27
µl), and pure water (27–0 µl) to prepare the sample solutions (30
µl) for the spectroscopy titration assays. After the incubation of
these sample solutions for 1-day, their UV-vis and CD spectra
were measured by using a V-630 UV-visible spectrophotometer
and a JASCO J-820 spectropolarimeter equipped with SAH-769
and MSD-462, respectively.
4.6. 1-(p-Aminophenyl)-2,3,4,2',3',4',6'-hexa-O-acetyl-
isomaltoside
To pNPIma in THF (70 ml), Pd/C (0.42 mg) was added and
the resultant mixture was vigorously stirred under H2 atmosphere
at ambient temperature for overnight. The resultant mixture was
filtrated through a celite pad and the filtrate was evaporated and
dried in vacuo. The residue was then subjected to purification on
silica-gel (CHCl3/MeOH = 50/1, v/v) to give the titled compound
(pAPIma) as white powder. This compound was used in the
1
following reaction without H/13C NMR, MS and IR spectral
4.10. MD simulations
characterizations.
Before the MD simulation of the molecular assembly
4.7. 5,5’-Bis-(-N-(p-O-(2,3,6,2,3,4,6-hepta-O-acetyl-
isomaltosyl)phenyl)-aminocarbonyl)-2,2'-bipyridine
(bpyImaAc)
β-
-
consisting of Λ-[Fe(bpyMal)3]2+ , K+, and NO3 , we built a Λ-
[Fe(bpyMal)3]2+ with a stable conformation through a molecular
mechanics (MM) calculation. Briefly, we constructed a Λ-
[Febpy3]2+ and then, its stable conformation was obtained through
its MM calculation. After the construction of Λ-[Febpy3]2+, the
spatial positions of all atoms in its structure were fixed. This
spatial fixing was essential to successfully achieve the MD
simulation on the three-component molecular assembly, since
CHARMm force field was not suitable for molecules having Fe-
N bonds. We then attached β-maltosyloxyphenylaminocarbonyl
(MalβPheNHCO-) units onto all C5 positions of the pyridine (py)
units of Λ-[Febpy3]2+ and constructed Λ-[Fe(bpyMal)3]2+ with E
and Z configurations about its C5py-CC=O bonds and amide bonds,
To pAPIma (0.37 g, 0.51 mmol) and Et3N (2 ml) in THF (65
ml), bpyCOCl prepared from 28 mg (0.11 mmol) of bpyCOOH
in THF (5.0 ml) was added and then, the resultant mixture was
stirred at the ambient temperature for 20 min. The resultant
reaction mixture was poured into iced water and diluted with
ethyl acetate. The organic layer was then washed with 0.5 N HCl
aq. and NaHCO3 saturated aqueous solution repeatedly. The
organic layer was dried over anhydrous Na2SO4, filtered, and
evaporated to give pale yellow syrup. The resultant syrup was
then subjected to silica-gel column chromatographic purification
process (hexane only ~ hexane/AcOEt = 1:9, gradient) to give the
titled compound (116 mg) in 61% yield (from bpyCOOH) as a
-
respectively. We then added K+ and NO3 ions nearby the
trivalent Mal clusters of Λ-[Fe(bpyMal)3]2+ to obtain the three-
component molecular assembly consisting of Λ-[Fe(bpyMal)3]2+,
1
pale yellow powder.; H NMR (300 MHz, CDCl3) δ 9.24 (d, J =
-
K+ and NO3 . Before starting the MD simulation, we applied
1.8 Hz, 2H), 8.70 (s, 2H), 8.58 (d, J = 8.4 Hz, 2H), 8.37 (dd, J =
2.1, 8.4 Hz, 2H), 7.76 (d, J = 9.0 Hz, 4H), 7.06 (d, J = 8.7 Hz,
4H), 5.41 (t, J = 9.6 Hz, 2H), 5.34 (t, J = 9.0 Hz, 2H), 5.25 (t, J =
9.7 Hz, 2H), 5.12–4.97 (m, 8H), 4.90 (dd, J = 3.9, 9.9 Hz, 2H),
4.19–4.14 (m, 2H), 4.01–3.76 (m, 8H), 3.48 (d, J = 9.6 Hz, 2H),
1.84 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 170.398, 170.357,
170.160, 170.094, 169.815, 169.675, 169.165, 163.649, 157.476,
153.974, 148.005, 136.085, 132.953, 130.684, 122.11, 121.420,
117.761, 101.147, 99.142, 76.198, 72.868, 72.548, 71.479,
70.953, 70.764, 69.111, 66.612, 62.017, 60.817, 20.831, 20.724,
20.659, 20.527. FT-IR (KBr, cm–1): 1754, 1509, 1370, 1224,
1038. MALDI-TOF-MS, [M+Na]+ = 1685.37 (calc. 1685.49).
distance restrictions (Fe2+-K+ and Fe2+-NO3 ) to this three-
-
-
component molecular assembly so that the ions (K+ and NO3 )
did not leave from Λ-[Fe(bpyMal)3]2+. The subsequent MD
simulation (CHARMm, ε = 80, 10 ps equilibrium, 90 ps
dynamics) gave the most stable conformation of the three-
component molecular assembly (Fig. 8).
4.11. Dropping test of metalloglycocluster solutions
According to the procedure described in section 4.9, we
prepared the aqueous metalloglycocluster solutions containing
varying concentrations of the chloride, nitrate, or sulfate salts.
After the 1-day incubation at ambient temperature, these
solutions were slowly expelled from a plastic syringe (Tuberculin
syringe, SS-01T, TERUMO Co., Japan) with a needle whose
outer and inner diameters were 0.72 and 0.41 mm, respectively.
The drops were weighed as they fell from the point of the needle.
4.8. 5,5’-Bis-(-N-(p-O-(β-isomaltosyl)phenyl)-
aminocarbonyl)-2,2'-bipyridine (bpyIma)
To bpyImaAc (0.67 g, 0.40 mmol) in methanol/THF (1:1, 50
ml), aqueous ammonia was added dropwise until pH value of the
resultant mixture became larger than 10. The resultant reaction
mixture was stirred at ambient temperature for overnight. After
confirming that the pH value of the reaction mixture was still
larger than 10, the resultant mixture was concentrated to form
white precipitate. The precipitate was retrieved through filtration
and dried over filter paper overnight to give the title compound
as a white powder (0.37 g, >99 %); dH (300 MHz, DMF-d7 +
D2O): 9.11 (t, J 1.5 Hz, 2H), 8.23 (d, J 1.5 Hz, 2H), 7.61 (d, J 9.0
Hz, 4H), 6.94 (d, J 9.0 Hz, 4H), 4.66 (d, J 7.8 Hz, 2H), 4.58 (d, J
3.9 Hz, 2H), 3.64-3.01 (m, 24H); dC (75 MHz, DMF-d7 + D2O):
162.9, 162.0, 156.2, 153.8, 148.2, 136.0, 132.6, 130.528, 121.2,
120.0, 116.2, 100.9, 98.2, 76.4, 74.5, 73.2, 73.1, 72.1, 71.8, 70.0,
79.8, 66.0, 60.7; HR-ESI-TOF-MS, [M+H]+ = 1075.3550 (calc.
1075.3519); nmax (KBr) 3375, 1647, 1542, 1508, 1417, 1224,
1078 cm-1.
Declaration of interest
Declarations of interest: none
Acknowledgements
This work was supported by Grant-in-Aid for Scientific
Research (No. 25810105) from the Ministry of Education,
Culture, Sports, Science and Technology, Japan and Special
Research Fund of Toyo University.
References and notes
1. Hirohashi N, Kamei N, Kubo H, Sawada H, Matsumoto M, Hoshi
M. Dev. Growth Differ. 2008;50:S221–S238.
2. Schengrund CL. Trends Biochem. Sci. 2015;40:397–406.
4.9. UV-vis and CD spectroscopy titration experiments